MOODY ALDRICH PARTNERS LLC — 13F Portfolio

Moody Aldrich Partners LLC is a Wilmington, Massachusetts-based registered investment advisory firm specializing in concentrated, quality-focused equity portfolio management. The firm files quarterly 13F reports with the SEC under CIK #0000936941, a filing history that extends back to the late 1990s — providing an exceptionally deep longitudinal record of the firm's publicly disclosed equity holdings spanning more than two decades and encompassing multiple complete market cycles. This extended filing tenure establishes Moody Aldrich Partners as a seasoned institutional equity manager with a verifiable track record of portfolio construction decisions through some of the most varied and challenging market environments in modern financial history. The firm was co-founded by Peter Moody and Christopher Aldrich, both of whom serve as Managing Partners and have guided the firm's investment philosophy and client relationships since its inception. The partnership structure — reflected in the firm's very name — underscores a culture of shared accountability, collaborative investment decision-making, and aligned interests between the firm's principals and its clients. Jason Escamilla serves as Chief Investment Officer, providing intellectual leadership for the firm's equity research process and portfolio construction methodology. This three-person senior leadership structure combines founding vision with dedicated investment management expertise, enabling the firm to maintain philosophical continuity while benefiting from specialized analytical rigor. Wilmington, Massachusetts — located in the greater Boston metropolitan area — situates Moody Aldrich Partners within one of the nation's premier financial and intellectual corridors. The Boston ecosystem provides unparalleled access to institutional research capabilities, world-class universities, healthcare and biotechnology enterprises, and a concentration of asset management firms that collectively define one of America's most important centers of investment management activity. This geographic positioning supports the firm's quality-growth equity mandate through proximity to corporate management teams, industry conferences, and the broader institutional research community that informs fundamental equity analysis. Moody Aldrich Partners serves a diverse client base spanning institutional accounts, high-net-worth individuals, and endowment-type entities. This institutional orientation distinguishes the firm from retail-focused advisory practices and reflects a level of investment sophistication and process discipline that meets the due diligence requirements of professional allocators and fiduciary investors. The firm's ability to attract and retain institutional mandates alongside private wealth clients speaks to the robustness of its investment process and the consistency of its portfolio management approach.

Moody Aldrich Partners employs a concentrated, quality growth equity strategy that seeks to identify and hold a focused portfolio of companies exhibiting durable competitive advantages, superior returns on invested capital, consistent earnings growth, and strong management execution. The firm's investment philosophy is rooted in the belief that exceptional businesses — purchased at reasonable prices and held with patience — compound wealth more effectively than diversified portfolios of mediocre companies or tactical trading strategies that attempt to time market fluctuations. This conviction-driven approach results in a portfolio that is significantly more concentrated than typical diversified equity strategies. Rather than spreading capital across dozens or hundreds of positions, Moody Aldrich Partners constructs a focused portfolio where each holding represents a thoroughly researched, high-conviction investment thesis. The concentration is a deliberate expression of the firm's intellectual confidence in its research process — a willingness to allocate meaningful capital to its best ideas rather than diluting potential alpha through excessive diversification. Examination of the firm's 13F Portfolio Composition across its extensive filing history reveals a consistent orientation toward high-quality, large-cap and mid-cap companies in sectors where competitive advantages are most durable and returns on capital are most sustainable. Technology, healthcare, industrials, and consumer sectors represent the primary hunting grounds for the firm's research process — sectors characterized by innovation-driven growth, intellectual property protection, network effects, and brand strength that create the kinds of enduring competitive moats the firm seeks. The Top 10 Holdings Concentration is notably elevated, reflecting the firm's concentrated conviction philosophy. In a portfolio with a limited number of total positions, the top ten holdings may represent a very substantial proportion of total disclosed equity value — a concentration level that underscores the firm's commitment to deep fundamental research on each position and its willingness to accept higher tracking error in pursuit of differentiated long-term outcomes. This level of concentration creates the potential for meaningful alpha generation when the firm's research thesis proves correct, but also introduces elevated single-name and sector-specific risk relative to more diversified approaches. Portfolio turnover is low, reflecting a patient, long-duration investment philosophy that allows the compounding power of high-quality businesses to work over extended holding periods. The firm's positions frequently persist across many sequential quarterly filings — in some cases for years — with sizing adjustments reflecting evolving conviction levels rather than tactical trading impulses. This low-turnover discipline is a natural extension of the quality growth framework: once the firm identifies a business with durable competitive advantages and sustainable growth characteristics, the optimal strategy is to hold that position and allow intrinsic value to compound rather than trading in and out based on short-term price fluctuations. The quality growth investment process is fundamentally bottom-up, driven by deep company-specific research rather than top-down macroeconomic forecasting or sector rotation strategies. Each potential investment is evaluated through a rigorous analytical framework that examines competitive positioning, addressable market dynamics, management quality, capital allocation discipline, margin trajectory, and valuation relative to the firm's assessment of long-term intrinsic value. This multi-dimensional fundamental analysis produces an investment mosaic that extends well beyond simple quantitative screening — incorporating qualitative judgments about business durability and management capability that cannot be captured by purely algorithmic processes. The firm's willingness to maintain concentration through varying market environments — holding quality positions during drawdowns rather than trading defensively — reflects a philosophical commitment to the principle that time in the market with superior businesses generates better outcomes than timing the market through tactical allocation shifts. This steady-state approach requires both intellectual conviction and emotional discipline, as concentrated portfolios inevitably experience periods of heightened volatility that test the patience of both managers and clients.

Moody Aldrich Partners LLC represents a distinctive and well-defined investment approach — concentrated quality-growth equity management executed with exceptional patience and philosophical consistency. Under the leadership of co-founders Peter Moody and Christopher Aldrich, with Jason Escamilla directing investment strategy, the firm has maintained a coherent investment identity across more than two decades of 13F filing history, demonstrating the kind of process stability that institutional allocators value when evaluating managers for long-term mandates. Key analytical dimensions observable through the firm's extensive filing record include elevated holdings concentration reflecting high-conviction stock selection; persistent orientation toward quality-growth sectors including technology, healthcare, industrials, and consumer sectors; exceptionally low portfolio turnover consistent with long-duration compounding conviction; and consistent bottom-up, fundamentals-driven portfolio construction across multiple complete market cycles. The Annualized Return (CAGR) derived from historical replication of the disclosed portfolio across the firm's multi-decade filing history provides a uniquely valuable long-duration compounding benchmark. For a concentrated quality-growth strategy, the CAGR reveals whether the firm's willingness to accept higher concentration risk and tracking error has been rewarded with genuinely superior long-term wealth creation — the fundamental premise underlying the entire investment philosophy. A portfolio simulator reconstructing the capital trajectory from the late 1990s through the present would encompass the full arc of modern equity market history, enabling evaluation of compounding behavior across regimes that alternately rewarded and penalized quality-growth concentration. The Alpha Generation vs S&P 500 metric provides the definitive test of the concentrated conviction approach. Concentrated strategies that fail to generate meaningful alpha over extended periods face a challenging value proposition, as investors could achieve similar or superior risk-adjusted outcomes through low-cost diversified index exposure with lower volatility and less tracking error. Conversely, concentrated strategies that demonstrate sustained alpha generation validate the premise that deep fundamental research and portfolio focus create a genuine informational edge that diversified approaches cannot replicate. The firm's longitudinal 13F history, accessible through backtesting service tools and performance backtests online, offers researchers an exceptional laboratory for studying the long-term dynamics of concentrated quality-growth investing. The Sector Allocation History across the complete filing archive traces the evolution of the firm's conviction positioning, revealing whether the quality screen has consistently identified opportunities in the same sectors or shifted its focus as competitive advantages migrated across the economy over time. A foundational diagnostic question for ongoing evaluation: As concentrated quality-growth strategies have attracted significant capital flows over the past decade — compressing the valuation discount that historically rewarded patient investors in competitively advantaged businesses — does Moody Aldrich Partners' two-decade investment process retain sufficient analytical edge and conviction discipline to continue generating alpha from a progressively more efficiently priced quality factor, or has the popularization of quality-growth investing as an explicit investment style fundamentally altered the opportunity set from which concentrated conviction managers draw their returns?

The risk architecture of Moody Aldrich Partners' portfolio is fundamentally defined by its concentration — the single most influential structural characteristic that shapes the strategy's volatility, drawdown behavior, and relative performance patterns. Concentrated portfolios introduce a distinctive risk-return tradeoff that allocators must evaluate carefully: the potential for meaningful alpha generation is accompanied by elevated tracking error, higher single-name exposure, and amplified sensitivity to sector-specific and company-specific events. The Volatility Profile is expected to exceed that of broadly diversified equity benchmarks, reflecting the mathematical reality that fewer positions result in less diversification benefit and greater portfolio sensitivity to individual holding movements. However, the firm's emphasis on quality — defined by strong balance sheets, durable competitive advantages, and consistent earnings — provides a partial offset to concentration-driven volatility. High-quality companies tend to exhibit lower earnings volatility and more resilient valuations during market stress, creating a portfolio where the elevated position-level volatility is partially mitigated by the fundamental stability of the underlying businesses. The Max Drawdown Depth observable through historical replication of the firm's 13F disclosures is a critically important metric given the concentrated portfolio construction. The firm's extensive filing history — spanning more than two decades — provides an unusually rich dataset for evaluating drawdown behavior across multiple severe market dislocations. The 2000-2002 technology bear market, the 2008-2009 global financial crisis, the 2011 European sovereign debt turmoil, the 2018 Q4 volatility event, the March 2020 pandemic crash, and the 2022 rate-driven correction each tested concentrated quality-growth portfolios in distinct ways. The cumulative drawdown record across all of these events provides a comprehensive behavioral fingerprint that reveals how the firm navigates crisis periods — whether concentration amplifies losses beyond benchmark levels or the quality screen provides sufficient fundamental resilience to limit drawdown severity. From a factor exposure perspective, the portfolio carries strong positive loadings to quality and growth factors, with potentially limited value exposure and moderate-to-high active share relative to broad benchmarks. This factor profile creates a portfolio that structurally benefits during quality-led and growth-led market environments but may face headwinds during value rotations or periods when market breadth expands to favor lower-quality, more cyclical companies. The 2022 growth-to-value rotation and the narrow AI-driven recovery of 2023 each tested different dimensions of this factor sensitivity. Concentration risk extends beyond individual position exposure to include sector concentration. If the firm's quality-growth screen consistently identifies opportunities within a limited number of sectors — particularly technology and healthcare — the portfolio may carry meaningful correlated sector exposure that amplifies drawdowns during sector-specific corrections. This sector concentration risk is a natural consequence of bottom-up stock selection within a quality framework, as high-quality businesses with durable competitive advantages are not uniformly distributed across all sectors of the economy. The low turnover provides behavioral risk management by reducing the frequency of active decision points where cognitive biases can introduce errors. Concentrated, patient managers who resist the urge to trade reactively during market stress avoid the realized-loss crystallization and timing errors that often afflict more active approaches. However, low turnover in a concentrated portfolio also means that the consequences of a flawed investment thesis can persist and compound — a risk that places extraordinary importance on the quality of the firm's initial research and ongoing monitoring processes.